A MISSION TO MODERNIZE THE SPECIALTY DRUG PROCESS
ZappRx is a health technology company that is modernizing and simplifying the way specialty medications are accessed. It was founded in 2012 by Zoë Barry after her youngest brother was diagnosed with severe epilepsy and was in need of specialized care and therapy. Since 2012, the company has launched its platform in multiple large clinical centers nationwide and raised $41 million in funding. In 2017, Qiming US Healthcare Fund, a venture capital firm based in Seattle that is part of a broader family of Qiming Venture Partners led the company’s Series B round of funding. This round included participation from SR One, who led ZappRx's Series A round in 2014, and GV (formerly Google Ventures).